Summit Therapeutics Inc (SMMT)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current SMMT market cap is 7.08B. The company's latest EPS is USD -0.8760 and P/E is -11.52.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 822k | 179k | 213k |
| Operating Income | -537.74M | -15.77M | -19.94M | -36.21M | -42.39M |
| Net Income | -542.38M | -14.72M | -21.27M | -36.57M | -43.47M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 23.62M | 20.17M | 22.78M | 15.12M | 1M |
| Operating Income | -27.47M | -53.19M | -86.19M | -72.09M | -609.65M |
| Net Income | -29.13M | -52.7M | -88.6M | -78.78M | -614.93M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 254.9M | 237.37M | 218.48M | 202.95M | 176.78M |
| Total Liabilities | 121.42M | 117.77M | 119.1M | 125.26M | 132.57M |
| Total Equity | 133.48M | 119.6M | 99.38M | 77.69M | 44.21M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 96.25M | 102.5M | 113.37M | 664.17M | 202.95M |
| Total Liabilities | 17.39M | 23.05M | 30.09M | 537.51M | 125.26M |
| Total Equity | 78.86M | 79.45M | 83.28M | 126.65M | 77.69M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -13.13M | -42.4M | -57.3M | -76.76M | -30.13M |
| Investing | -645.06M | -644.86M | -648.34M | -587.77M | 19.87M |
| Financing | 80.11M | 80.03M | 80.26M | 86.51M | 485k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -20.76M | -48.11M | -72.59M | -41.58M | -76.76M |
| Investing | -341k | -421k | -306k | -624k | -587.77M |
| Financing | 49.51M | 50.55M | 77.92M | 620.24M | 86.51M |
| Market Cap | 7.08B |
| Price to Earnings Ratio | -11.52 |
| Price to Sales Ratio | 7.21k |
| Price to Cash Ratio | 99.21 |
| Price to Book Ratio | 91.17 |
| Dividend Yield | - |
| Shares Outstanding | 701.98M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.04 (0.4%) |
| Company Name | Summit Therapeutics Inc |
| Address |
850 new burton road suite 201 wilmington, delaware 19904 |
| Website | https://www.smmttx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
